An Update on Immuno-Oncologic Therapeutics to Improve Outcomes for Patients With Advanced Melanoma
WebcastFaculty
OVERVIEW
An Update on Immuno-Oncologic Therapeutics to Improve Outcomes for Patients With Advanced Melanoma is organized by Academic CME and will be held during Mar 13, 2017 - Mar 12, 2018.
The target audience for this medical event is Dermatologists, oncologists, and other healthcare clinicians responsible for the care of patients with melanoma. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Conference Objectives are :
• Review the therapeutic science of melanoma, including the role of immuno-oncologic agents for the treatment of previously untreated and/or metastatic disease.
• Analyze clinical trial data of emerging immuno-oncology combination regimens for the treatment of advanced melanoma.
Additional details will be posted as soon as they are available.
The target audience for this medical event is Dermatologists, oncologists, and other healthcare clinicians responsible for the care of patients with melanoma. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Conference Objectives are :
• Review the therapeutic science of melanoma, including the role of immuno-oncologic agents for the treatment of previously untreated and/or metastatic disease.
• Analyze clinical trial data of emerging immuno-oncology combination regimens for the treatment of advanced melanoma.
Additional details will be posted as soon as they are available.
SPECIALITIES
Oncology
Quick Links